Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: A retrospective database study

Journal of Thrombosis and Thrombolysis

Volumn 34, Issue 4, 2012, Pages 446-456

  Huang, Huan ^a   Korn, Jonathan R ^a   Mallick, Rajiv ^b   Friedman, Mark ^a   Nichols, Christine ^a   Menzin, Joseph ^a  

^a Boston Health Economics Inc   (United States)

^b DAIICHI SANKYO INC   (United States)

Author keywords

Chemotherapy; Incidence; Lung cancer; Mortality; Venous thromboembolism

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; CYTOTOXIC AGENT; ERLOTINIB; PEMETREXED; PLATINUM COMPLEX; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAID; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; VENOUS THROMBOEMBOLISM;

ADULT; AGED; CATHETERIZATION, CENTRAL VENOUS; DATABASES, FACTUAL; FEMALE; FLORIDA; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MEDICARE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; UNITED STATES;

EID: 84868196308     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0741-7     Document Type: Article

References (35)

1. Chew HK, Davies AM, Wun T, Harvey D, Zhou H, White RH (2008) The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost 6(4):601-608 (Pubitemid 351404927)
2. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110(10):2339-2346 (Pubitemid 350100757)
3. Blom JW, Osanto S, Rosendaal FR (2004) The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost 2(10):1760-1765 (Pubitemid 40192717)
4. Bick RL (2003) Cancer-associated thrombosis. N Engl J Med 349(2):109-111 (Pubitemid 36818779)
5. Khorana AA, Francis CW, Culakova E, Lyman GH (2005) Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 104(12):2822-2829 (Pubitemid 41798294)
6. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5(3):632-634 (Pubitemid 46680709)
7. Paneesha S, Lokare A, Lester Z, Nokes T, Arya R, Farren T et al (2009) Impact of venous thromboembolism on survival in patients with malignancy. Br J Haematol 145(2):258-260
8. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343(25):1846-1850 (Pubitemid 32104130)
9. Fotopoulou C, duBois A, Karavas AN, Trappe R, Aminossadati B, Schmalfeldt B et al. (2008) Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie ovarian cancer study group. J Clin Oncol 26(16):2683-2689
10. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al (2008) Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edn). Chest 133(6 Suppl):381S-453S (Pubitemid 351894916)
11. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M et al (2007) American society of clinical oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25(34):5490-5505 (Pubitemid 350232226)
12. Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. J Am Med Assoc 293(6):715-722 (Pubitemid 40216041)
13. Elting LS, Escalante CP, Cooksley C, Avritscher EB, Kurtin D, Hamblin L et al (2004) Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med 164(15):1653-1661 (Pubitemid 39037944)
14. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R et al (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78(5):285-291 (Pubitemid 29439263)
15. Spyropoulos AC, Hussein M, Lin J, Battleman D (2009) Rates of venous thromboembolism occurrence in medical patients among the insured population. Thromb Haemost 102(5):951-957
16. White RH, Chew HK, Zhou H, Parikh-Patel A, Harris D, Harvey D et al (2005) Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med 165(15):1782-1787 (Pubitemid 41138968)
17. Florida Agency for Health Care Administration (2010) Medicaid, AHCA 2010. http://www.fdhc.state.fl.us/medicaid/. Accessed 29 November 2010
18. Hankin CS, Cox L, Lang D, Levin A, Gross G, Eavy G et al (2008) Allergy immunotherapy among medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol 121(1):227-232
19. Hankin CS, Koran LM, Bronstone A, Black DW, Sheehan DV, Hollander E et al (2009) Adequacy of pharmacotherapy among medicaid-enrolled patients newly diagnosed with obsessive-compulsive disorder. CNS Spectr 14(12):695-703
20. Hankin CS, Cox L, Lang D, Bronstone A, Fass P, Leatherman B et al (2010) Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study. Ann Allergy Asthma Immunol 104(1):79-85
21. Marton JP, Boulanger L, Friedman M, Dixon D, Wilson J, Menzin J (2006) Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective. Respir Med 100(6):996-1005
22. Lang K, Sussman M, Friedman M, Su J, Kan HJ, Mauro D et al (2009) Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 135(6):582-588
23. Zhang B, Hepner DL, Tran MH, Friedman M, Korn JR, Menzin J (2009) Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries. Curr Med Res Opin 25(4):943-950
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373-383 (Pubitemid 17055592)
25. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613-619
26. Duh MS, Reynolds WJ, Lefebvre P, Neary M, Skarin AT (2008) Costs associated with intravenous chemotherapy administration in patients with small cell lung cancer: a retrospective claims database analysis. Curr Med Res Opin 24(4):967-974 (Pubitemid 351579153)
27. Suenaga M, Mizunuma N, Kobayashi K, Shinozaki E, Matsusaka S, Chin K et al (2010) Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab. Med Oncol 27(3):807-814
28. Rasco DW, Yan J, Xie Y, Dowell JE, Gerber DE (2010) Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse population. J Thorac Oncol 5(10):1529-1535
29. Connolly GC, Dalal MR, Lin J, Khorana AA, University of Rochester RN, Sanofi-Aventis BN et al. (2011) Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer. American Society of Clinical Oncology (ASCO). http://www.asco.org/ascov2/Meetings/ Abstracts?&vmview=abst-detail-view&confID=102&abstractID=79817. Accessed 26 May 2011
30. de Meis E, Pinheiro VR, Zamboni MM, Guedes MT, Castilho IA, Martinez MM et al. (2009) Clotting, immune system, and venous thrombosis in lung adenocarcinoma patients: a prospective study. Cancer Invest 27(10):989-997
31. Numico G, Garrone O, Dongiovanni V, Silvestris N, Colantonio I, Di CG et al (2005) Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. Cancer 103(5):994-999 (Pubitemid 40270076)
32. Tagalakis V, Levi D, Agulnik JS, Cohen V, Kasymjanova G, Small D (2007) High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients. J Thorac Oncol 2(8):729-734 (Pubitemid 47357525)
33. Schneeweiss S, Avorn J (2005) A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 53(327):337
34. Falanga A, Zacharski L (2005) Deep vein thrombosis in cancer: the scale of the problem and approaches to management. Ann Oncol 16(5):696-701 (Pubitemid 40767088)
35. Thompson C, Rodgers R (1952) Analysis of the autopsy records of 157 cases of carcinoma of the pancreas with particular reference to the incidence of thromboembolism. Am J Med Sci 223:469-476